Practical considerations for measuring the effective reproductive number, Rt.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
12 2020
Historique:
entrez: 10 12 2020
pubmed: 11 12 2020
medline: 19 12 2020
Statut: epublish

Résumé

Estimation of the effective reproductive number Rt is important for detecting changes in disease transmission over time. During the Coronavirus Disease 2019 (COVID-19) pandemic, policy makers and public health officials are using Rt to assess the effectiveness of interventions and to inform policy. However, estimation of Rt from available data presents several challenges, with critical implications for the interpretation of the course of the pandemic. The purpose of this document is to summarize these challenges, illustrate them with examples from synthetic data, and, where possible, make recommendations. For near real-time estimation of Rt, we recommend the approach of Cori and colleagues, which uses data from before time t and empirical estimates of the distribution of time between infections. Methods that require data from after time t, such as Wallinga and Teunis, are conceptually and methodologically less suited for near real-time estimation, but may be appropriate for retrospective analyses of how individuals infected at different time points contributed to the spread. We advise caution when using methods derived from the approach of Bettencourt and Ribeiro, as the resulting Rt estimates may be biased if the underlying structural assumptions are not met. Two key challenges common to all approaches are accurate specification of the generation interval and reconstruction of the time series of new infections from observations occurring long after the moment of transmission. Naive approaches for dealing with observation delays, such as subtracting delays sampled from a distribution, can introduce bias. We provide suggestions for how to mitigate this and other technical challenges and highlight open problems in Rt estimation.

Identifiants

pubmed: 33301457
doi: 10.1371/journal.pcbi.1008409
pii: PCOMPBIOL-D-20-01122
pmc: PMC7728287
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1008409

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM122876
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007535
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM088558
Pays : United States
Organisme : Wellcome Trust
ID : 210758/Z/18/Z
Pays : United Kingdom

Commentaires et corrections

Type : UpdateOf
Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Swiss Med Wkly. 2020 May 04;150:w20271
pubmed: 32365217
PLoS One. 2015 Mar 20;10(3):e0118762
pubmed: 25793993
medRxiv. 2020 Apr 29;:
pubmed: 32511293
Biometrics. 2014 Dec;70(4):993-1002
pubmed: 24930473
Epidemics. 2014 Dec;9:70-8
pubmed: 25480136
PLoS One. 2008 May 14;3(5):e2185
pubmed: 18478118
PLoS Comput Biol. 2020 Apr 6;16(4):e1007735
pubmed: 32251464
Elife. 2020 Jun 22;9:
pubmed: 32568070
Proc Biol Sci. 2015 Dec 22;282(1821):20152026
pubmed: 26674948
JAMA. 2020 May 19;323(19):1915-1923
pubmed: 32275295
Am J Epidemiol. 2013 Nov 1;178(9):1505-12
pubmed: 24043437
Am J Epidemiol. 2006 Sep 15;164(6):591-7
pubmed: 16887892
Euro Surveill. 2020 Apr;25(17):
pubmed: 32372755
Proc Biol Sci. 2007 Feb 22;274(1609):599-604
pubmed: 17476782
Epidemiol Perspect Innov. 2010 Dec 15;7:12
pubmed: 21159178
J R Soc Interface. 2019 Jan 31;16(150):20180670
pubmed: 30958162
Science. 2003 Jun 20;300(5627):1966-70
pubmed: 12766207
Swiss Med Wkly. 2020 Jul 13;150:w20307
pubmed: 32658987
Stat Med. 1991 Oct;10(10):1527-42
pubmed: 1947509
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21825-9
pubmed: 20080801
Am J Epidemiol. 2004 Sep 15;160(6):509-16
pubmed: 15353409
Epidemiology. 2019 Sep;30(5):737-745
pubmed: 31205290
J R Soc Interface. 2020 Jun;17(167):20190719
pubmed: 32574542
Am J Epidemiol. 2012 Aug 1;176(3):196-203
pubmed: 22791742
PLoS One. 2007 Aug 22;2(8):e758
pubmed: 17712406
Science. 2020 May 8;368(6491):
pubmed: 32234805
Science. 2020 Aug 28;369(6507):1106-1109
pubmed: 32694200
Emerg Infect Dis. 2006 Jan;12(1):110-3
pubmed: 16494726
Biom J. 2021 Mar;63(3):490-502
pubmed: 33258177
Epidemics. 2019 Jun;27:12-18
pubmed: 30799184
Int J Infect Dis. 2020 Apr;93:284-286
pubmed: 32145466
Influenza Other Respir Viruses. 2009 Nov;3(6):267-76
pubmed: 19903209
Am J Epidemiol. 2021 Sep 1;190(9):1908-1917
pubmed: 33831148
Science. 2020 Jul 10;369(6500):
pubmed: 32414780
Epidemics. 2019 Dec;29:100356
pubmed: 31624039
Emerg Themes Epidemiol. 2014 Mar 21;11(1):4
pubmed: 24656239
Epidemiol Infect. 2020 May 18;148:e97
pubmed: 32418559
Emerg Infect Dis. 2020 Jun;26(6):1341-1343
pubmed: 32191173
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059
Swiss Med Wkly. 2020 May 30;150:w20295
pubmed: 32472939
Math Biosci. 2007 Jul;208(1):300-11
pubmed: 17174352
Elife. 2022 Aug 08;11:
pubmed: 35938911

Auteurs

Katelyn M Gostic (KM)

Department of Ecology and Evolution, University of Chicago, Chicago, IL, United States of America.

Lauren McGough (L)

Department of Ecology and Evolution, University of Chicago, Chicago, IL, United States of America.

Edward B Baskerville (EB)

Department of Ecology and Evolution, University of Chicago, Chicago, IL, United States of America.

Sam Abbott (S)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Keya Joshi (K)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States of America.

Christine Tedijanto (C)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States of America.

Rebecca Kahn (R)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States of America.

Rene Niehus (R)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States of America.

James A Hay (JA)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States of America.

Pablo M De Salazar (PM)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States of America.

Joel Hellewell (J)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Sophie Meakin (S)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

James D Munday (JD)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Nikos I Bosse (NI)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Katharine Sherrat (K)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Robin N Thompson (RN)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Mathematical Institute, University of Oxford, Oxford, United Kingdom.

Laura F White (LF)

Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States of America.

Jana S Huisman (JS)

Department of Environmental Systems Science, ETH Zürich, Zürich, Switzerland.
Department of Biosystems Science and Engineering, ETH Zürich, Switzerland.

Jérémie Scire (J)

Department of Biosystems Science and Engineering, ETH Zürich, Switzerland.
Swiss Institute of Bioinformatics, Basel, Switzerland.

Sebastian Bonhoeffer (S)

Department of Environmental Systems Science, ETH Zürich, Zürich, Switzerland.

Tanja Stadler (T)

Department of Biosystems Science and Engineering, ETH Zürich, Switzerland.
Swiss Institute of Bioinformatics, Basel, Switzerland.

Jacco Wallinga (J)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, the Netherlands.

Sebastian Funk (S)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Marc Lipsitch (M)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States of America.

Sarah Cobey (S)

Department of Ecology and Evolution, University of Chicago, Chicago, IL, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH